TY - JOUR
T1 - Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13)
T2 - A kinetic analysis
AU - Jayakumar, Arumugam
AU - Kang, Ya'an
AU - Frederick, Mitchell J.
AU - Pak, Stephen C.
AU - Henderson, Ying
AU - Holton, Paula R.
AU - Mitsudo, Kenji
AU - Silverman, Gary A.
AU - EL-Naggar, Adel K.
AU - Brömme, Dieter
AU - Clayman, Gary L.
N1 - Funding Information:
This work was supported in part by National Institute of Dental Research Grant 1-P50-DE11906-01 (G.L.C.), National Institute of Health Independent Award 1R01DE13954-01 (G.L.C.), National Institute of Health First Investigator Award R29DE11689 (G.L.C.), Cancer Center Support Grant CA60374-00, the Michael A. O’Bannon Endowment of Cancer Research, the Betty Berry Cancer Research Fund, funds from the M.D. Anderson Cancer Center’s Tobacco Research Program and the Texas Legislative Tobacco Settlement, and National Institutes of Health Grants CA87006 (G.A.S.) and CA86002 (G.A.S.).
PY - 2003/1/15
Y1 - 2003/1/15
N2 - Headpin (SERPINB13) is a novel member of the serine proteinase inhibitor (Serpin) gene family that was originally cloned from a keratinocyte cDNA library. Western blot analysis using a headpin-specific antiserum recognized a protein with the predicted Mr of 44kDa in lysates derived from a transformed keratinocyte cell line known to express headpin mRNA. Similarity of the reactive-site loop (RSL) domain of headpin, notably at the P1-P1′ residues, with other serpins that inhibit cysteine and serine proteinases suggests that headpin may inhibit similar proteinases. This study demonstrates that recombinant headpin indeed inhibits cathepsins K and L, but not chymotrypsin, elastase, trypsin, subtilisin A, urokinase-type plasminogen activator, plasmin, or thrombin. The second-order rate constants (ka) for the inhibitory reactions of rHeadpin with cathepsins K and L were 5.1±0.6×104 and 4.1±0.8×104M-1s-1, respectively. Headpin formed SDS-stable complexes with cathepsins K and L, a characteristic property of inhibitory serpins. Interactions of the RSL domain of headpin with cathepsins K and L were indicated by cleavage of headpin near the predicted P1-P1′ residues by these proteinases. These results demonstrate that the serpin headpin possesses specificity for inhibiting lysosomal cysteine proteinases.
AB - Headpin (SERPINB13) is a novel member of the serine proteinase inhibitor (Serpin) gene family that was originally cloned from a keratinocyte cDNA library. Western blot analysis using a headpin-specific antiserum recognized a protein with the predicted Mr of 44kDa in lysates derived from a transformed keratinocyte cell line known to express headpin mRNA. Similarity of the reactive-site loop (RSL) domain of headpin, notably at the P1-P1′ residues, with other serpins that inhibit cysteine and serine proteinases suggests that headpin may inhibit similar proteinases. This study demonstrates that recombinant headpin indeed inhibits cathepsins K and L, but not chymotrypsin, elastase, trypsin, subtilisin A, urokinase-type plasminogen activator, plasmin, or thrombin. The second-order rate constants (ka) for the inhibitory reactions of rHeadpin with cathepsins K and L were 5.1±0.6×104 and 4.1±0.8×104M-1s-1, respectively. Headpin formed SDS-stable complexes with cathepsins K and L, a characteristic property of inhibitory serpins. Interactions of the RSL domain of headpin with cathepsins K and L were indicated by cleavage of headpin near the predicted P1-P1′ residues by these proteinases. These results demonstrate that the serpin headpin possesses specificity for inhibiting lysosomal cysteine proteinases.
KW - Cysteine proteinases
KW - Headpin
KW - Insect cells
KW - Proteinase inhibition
KW - Serine proteinase inhibitor
UR - http://www.scopus.com/inward/record.url?scp=0037440423&partnerID=8YFLogxK
U2 - 10.1016/S0003-9861(02)00635-5
DO - 10.1016/S0003-9861(02)00635-5
M3 - Article
C2 - 12504904
AN - SCOPUS:0037440423
SN - 0003-9861
VL - 409
SP - 367
EP - 374
JO - Archives of Biochemistry and Biophysics
JF - Archives of Biochemistry and Biophysics
IS - 2
ER -